5-lipoxygenase as an endogenous modulator of amyloid β formation in vivo.

5-lipoxygenase as an endogenous modulator of amyloid β formation in vivo.
复制标题

DOI:
10.1002/ana.22234
复制
发表时间:
2011-01
影响因子:
11.2
通讯作者:
Pratico, Domenico
Pratico, Domenico
中科院分区:
医学1区
文献类型:
--
作者:
Chu, Jin;Pratico, Domenico

文献摘要

参考文献

被引文献

相似文献

5-脂氧合酶(5-LO)酶途径广泛分布于中枢神经系统内,并且在阿尔茨海默病中上调。然而,它可能影响疾病发病机制的机制仍然难以捉摸。本研究从药理学和遗传学角度探讨了5-LO在体内外调节β淀粉样蛋白(Aβ)形成的分子机制。我们发现5-LO通过激活cAMP反应元件结合蛋白(CREB)调节Aβ的形成,而CREB反过来又增加γ-分泌酶复合物的转录。通过药理学抑制或显性失活突变体阻止CREB活化可阻断Aβ形成的5-LO依赖性升高以及γ-分泌酶mRNA和蛋白水平的增加。此外,5-LO靶向基因破坏或其体内选择性药理学抑制导致Aβ、CREB和γ-分泌酶水平显著降低。这些数据确立了5-LO在调节中枢神经系统内源性Aβ水平形成中的新功能作用。因此,5-LO药理学抑制可能有益于阿尔茨海默病的治疗和预防。
The 5-lipoxygenase (5-LO) enzymatic pathway is widely distributed within the central nervous system, and is up-regulated in Alzheimer's disease. However, the mechanism whereby it may influence the disease pathogenesis remains elusive. We evaluated the molecular mechanism by which 5-LO regulates Amyloid β (Aβ) formation in vitro and in vivo by pharmacological and genetic approaches. Here we show that 5-LO regulates the formation of Aβ by activating the cAMP-response element binding protein (CREB), which in turn increases transcription of the γ-secretase complex. Preventing CREB activation by pharmacologic inhibition or dominant negative mutants blocks the 5-LO-dependent elevation of Aβ formation and the increase of γ-secretase mRNA and protein levels. Moreover, 5-LO targeted gene disruption or its in vivo selective pharmacological inhibition results in a significant reduction of Aβ, CREB and γ-secretase levels. These data establish a novel functional role for 5-LO in regulating endogenous formation of Aβ levels in the central nervous system. Thus, 5-LO pharmacological inhibition may be beneficial in the treatment and prevention of Alzheimer's disease.
DOI: 10.1016/s0002-9440(10)63724-8
发表时间: 2004-05-01
影响因子: 6
作者:
Praticò, D;Zhukareva, V;Lee, VMY
通讯作者: Lee, VMY
DOI: 10.1096/fasebj.12.6.439
发表时间: 1998-04-01
期刊: FASEB JOURNAL
影响因子: 4.8
作者:
Uz, T;Pesold, C;Manev, H
通讯作者: Manev, H
DOI: 10.1128/mcb.24.2.865-874.2004
发表时间: 2004-01-01
影响因子: 5.3
作者:
Christensen, MA;Zhou, WH;Song, WH
通讯作者: Song, WH
DOI: 10.1016/j.neurobiolaging.2006.06.007
发表时间: 2007-09-01
影响因子: 4.2
作者:
Chinnici, Cinzia M.;Yao, Yuemang;Pratico, Domenico
通讯作者: Pratico, Domenico
DOI: 10.1194/jlr.m500369-jlr200
发表时间: 2006-04-01
影响因子: 6.5
作者:
Dronadula, N;Rizvi, F;Rao, GN
通讯作者: Rao, GN